STAT3 and neoplasm: Similarly, the 5-year disease-free survival rate for patients with positive p-Stat3 expression and negative p-Stat3 expression was 76.8 and 92.3%, respectively, and the disease-free survival rate in patients with negative tumours was significantly higher than that in patients with positive tumours (P=0.010; log-rank test; Figure 3B).